ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | -33.3% | 1,500 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $9,000 | +50.0% | 1,500 | 0.0% | 0.01% | +40.0% |
| Q1 2019 | $6,000 | +100.0% | 1,500 | 0.0% | 0.01% | +150.0% |
| Q4 2018 | $3,000 | – | 1,500 | +1400.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | -50.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -75.0% | 200 | -72.4% | 0.00% | -100.0% |
| Q4 2016 | $4,000 | +300.0% | 724 | +262.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -80.0% | 200 | -66.7% | 0.00% | -100.0% |
| Q4 2015 | $5,000 | +150.0% | 600 | +177.8% | 0.00% | +200.0% |
| Q3 2015 | $2,000 | – | 216 | +575.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 32 | -89.8% | 0.00% | -100.0% |
| Q1 2015 | $3,000 | 0.0% | 315 | -37.0% | 0.00% | 0.0% |
| Q4 2014 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |